Article
Washington - A glycoprotein vaccine has induced significant protection against genital herpes disease in women with no evidence of either herpes simplex virus 1 or HSV 2 infection, said Stephen K. Tyring, M.D., Ph.D., at the annual meeting of the American Academy of Dermatology.
Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds
Melinda Gooderham, MD, MSc, FRCPC: Minimal Systemic Exposure of Delgocitinib Cream in Chronic Hand Eczema
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Celebrating Women’s History Month 2025 with Dermatology Times
2 Commerce Drive
Cranbury, NJ 08512